Info

Ventana Medical is one of the world's leading developers and manufacturers of medical diagnostic instrument and reagent systems providing leading-edge automation technology for use in slide-based diagnosis of cancer and infectious disease. Our products are found in hospital-based histology laboratories, independent reference laboratories, and the drug discovery laboratories of some of the world's largest pharmaceutical and biotechnology companies, government labs, and medical research centers. We serve our customers through wholly owned subsidiaries in the US, Europe, Japan and Australia and our instruments are installed in no fewer than 55 countries. "Ventana" is the Spanish word for "window". At Ventana Medical we provide innovative technology to open a window to the basic unit of life , the cell , thereby providing a better understanding of disease and targeted treatment. Dr. Thomas Grogan was a practicing pathologist at the University of Arizona when he founded Ventana more than 20 years ago on the strength of his vision for automating the manual IHC staining process. In 1991, Ventana launched its first ground-breaking instrument and reagent system and went public in 1996 to raise capital to fund further research. Today, we're a global organization providing healthcare professionals with superior automated instrument and reagent systems that standardize and speed slide staining in support of identifying treatment solutions that help people live better and longer lives. A global presence demonstrates our commitment to providing state-of-the-art technology to practicing healthcare professionals around the world. Originally focused on standardizing the preparation and staining of tissue or cells mounted on a glass microscope slide for examination by a pathologist, Ventana has evolved to meet the broader demands of today's laboratories. Innovative instrument and reagent systems are Ventana's mainstay. In addition, the Company offers broader workflow solutions and patient information management tools. All together, our systems incorporate learning gained over 20 years and many millions of research dollars. Our instrument and reagent systems are integrated to work seamlessly in providing users with superior quality and the most accurate results possible. At Ventana we are helping our customers change the practice of medicine. Through the standardization and speed afforded by automation, we are delivering the tools to help firmly establish the role of pathology as a partner in the delivery of top quality health care. From supplying innovative tools to researchers working on drug discovery to hospital based laboratories making diagnoses for use in establishing therapy, we are committed to delivering superior products in support of improving patient care. At Ventana we're passionate about Clinical Diagnostics and work to continuously set and then surpass current standards. At Ventana we're excited about the recent advances in understanding the human genome and associated impact on the field of drug discovery. The knowledge derived in both proteomics (the study of proteins and their function) and genomics (the study of genes and their function) is establishing exciting new opportunities for pathologists around the world. Indeed, automated Ventana systems are used by many leading research labs and pharmaceutical and biotechnology companies to assist in speeding the discovery of new drug targets that can cure and perhaps one day eliminate some diseases. Today our instrument and reagent systems are used in the majority of the top cancer centers in the world. The future is bright for Ventana. We have the financial and intellectual capital to partner successfully with the healthcare community. As an organization we are singularly focused on delivering the best possible tools in the fight against disease. What good is innovation if it is not touching lives?